Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Breast Cancer Research : BCR|May 27, 2026
CDK4/6 inhibitors rechallenge post-progression in HR-positive HER2-negative advanced/metastatic breast cancer patients: a meta-analysis of Kaplan-Meier-reconstructed individual-level dataJasmina Veta Darkovski, Isabella Michelon, Gabriela Gazzoni, et al.Current Issues in Molecular Biology|November 24, 2022
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric CancerAviva Atri-Schuller, Hassan Abushukair, Ludimila Cavalcante, et al.Vaccines|August 26, 2023
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular CarcinomaAlireza Tojjari, Ahmed Saeed, Meghana Singh, et al.BMC Cancer|February 12, 2024
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysisErfan Taherifard, Muhammad Bakhtiar, Mahnoor Mahnoor, et al.Current Treatment Options in Oncology|February 19, 2024
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?Suhaib Khateeb, Ludimila Cavalcante, Noor Alnairat, et al.Asian Pacific Journal of Cancer Prevention : APJCP|May 30, 2014
Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosisSimon Blechman Zeichner, Ludimila Cavalcante, Gabriel Pius Suciu, et al.Cancer Reports (Hoboken, N.J.)|June 1, 2026
MITF Gain-of-Function Mutation in Metastatic Prostate Cancer: A Rare Finding With Potential Therapeutic SignificancePaul J Pecorin, Nyembezi Dhliwayo, Matthew Demetrious, et al.Cancers|August 12, 2023
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-AnalysisJonathan N Priantti, Maysa Vilbert, Thiago Madeira, et al.Cancer Treatment Reviews|January 13, 2025
Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: A systematic review and updated meta-analysisIsabella Michelon, Caio E R Castro, Thiago Madeira, et al.Journal of Personalized Medicine|July 27, 2024
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-AnalysisIsabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro, et al.Pageof 4